Skip to main content
Premium Trial:

Request an Annual Quote

BioFocus Adds Waters' Xevo Mass Spec Tool

NEW YORK (GenomeWeb News) — Contract research company BioFocus DPI said today that it has installed a Waters Xevo TQ Mass Spectrometer for use in its drug metabolite discovery services for pharmaceutical clients.

Using the Xevo alongside Waters' UltraPerformance liquid chromatography technology will increase the lab’s throughput and "allows more accurate measurements to both quantify and confirm the identity of metabolites in a wide range of biological fluids and tissues," enabling an increased likelihood of metabolite detection, the company said.

Financial terms of the agreement were not released.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.